Io Therapeutics is a biotechnology company developing a series of retinoid and rexinoid compounds.
Io Therapeutics has raised $4.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2023.
Io Therapeutics is headquartered in Santa Ana, United States.
Io Therapeutics is a biotechnology company developing a series of retinoid and rexinoid compounds.
Io Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Io Therapeutics — Funding & Investors." VCBacked, March 1, 2023, https://www.vcbacked.co/company/io-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Io Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/io-therapeutics
{{cite web |title=Io Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/io-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated